PCI Biotech: Fourth quarter 2012 and preliminary 2012 results


Oslo, Norway, 5 February 2013.

Please find attached the presentation and report for Q4 2012 and preliminary full year 2012.

The presentation will be held the 5 February at 0800 at Felix Konferansesenter.

Kind regards,

Per Walday
CEO

Email: pw@pcibiotech.no
Mobil: +47 917 93 429

 
 
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachments

PCI Biotech Q4 2012 Presentation PCI Biotech Q4 2012 Report